Innovating Works

Georg-Speyer-Haus

Desconocido
PLASTICAN: Cell Plasticity in Metastatic Colorectal Cancer CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG tramitó un H2020 ERC-2020-ADG Colorectal cancer (CRC) belongs to the most frequent tumor entities in both men and women. Although early detection and certain therapies ha...
2021-12-06 - 2026-12-31 | Financiado
INTERCEPT-MDS: Exploring cell to cell heterogeneity and exploiting epigenetic regulation for the interception of my... CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un H2020 H2020-MSCA-ITN-2020 Disease interception is a novel concept referring to treatment of a disease before the disease fully develops by removing altered cells. To...
2020-08-13 - 2024-12-31 | Financiado
EUbOPEN: EUbOPEN Enabling and Unlocking biology in the OPEN CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un H2020 H2020-JTI-IMI2-2019-17-two-stage The EUbOPEN partnership of excellence will aim to generate the largest freely available set of high-quality chemical inhibitors for human pr...
2020-05-11 - 2025-04-30 | Financiado
HemNichMDS: Functional and Molecular Analyses of the Interplay between Hematopoietic and Mesenchymal Niche Cells... CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG tramitó un H2020 ERC-2014-STG Myelodysplastic syndromes (MDS) are heterogeneous clonal hematopoietic stem cell diseases mainly affecting the elderly (45/100,000 in >70 ye...
2015-07-08 - 2022-01-31 | Financiado
ROSCAN: The role of ROS RNS during inflammation associated and sporadic carcinogenesis CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG tramitó un FP7 "A link between inflammation and cancer has been suspected over a long period of time and in recent years genetic evidence supporting such n...
Financiado
CELL-PID: Advanced Cell based Therapies for the treatment of Primary ImmunoDeficiency CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un FP7 Primary immune deficiencies (PID) are inherited disorders of the adaptive and innate immune system marked by severe infections, autoimmunity...
Financiado
PERSIST: Persisting Transgenesis CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un FP7 For many disabling or fatal diseases, there is pre-clinical or clinical evidence of the potential therapeutic efficacy of gene therapy and,...
Financiado
NET4CGD: Gene Therapy for X linked Chronic Granulomatous Disease CGD CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORGSPEYERHAUS STIFTUNG participó en un FP7 This project is focused on the clinical development of a new orphan drug that can rapidly become a new treatment option for patients with th...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.